Article
Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes.
Gynecologic oncology - 1 Mar 2024
Praiss Aaron M, White Charlie, Iasonos Alexia, Selenica Pier, Zivanovic Oliver, Chi Dennis S, Abu-Rustum Nadeem R, Weigelt Britta, Aghajanian Carol, Girshman Jeffrey, Park Kay J, Grisham Rachel N
Abstract excerpt
OBJECTIVES: Mesonephric (MA) and mesonephric-like (MLA) adenocarcinomas are rare cancers, and data on clinical behavior and response to therapy are limited. We sought to report molecular features, treatment, and outcomes of MA/MLA from a single institution. METHODS: Patients with MA (cervix) or MLA (uterus, ovary, other) treated at Memorial Sloan Kettering Cancer Center (MSK) from 1/2008-12/2021 underwent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
